TH155318A - Co-crystals and salts of CCR3 inhibitors - Google Patents
Co-crystals and salts of CCR3 inhibitorsInfo
- Publication number
- TH155318A TH155318A TH1301001875A TH1301001875A TH155318A TH 155318 A TH155318 A TH 155318A TH 1301001875 A TH1301001875 A TH 1301001875A TH 1301001875 A TH1301001875 A TH 1301001875A TH 155318 A TH155318 A TH 155318A
- Authority
- TH
- Thailand
- Prior art keywords
- substance
- crystals
- formula
- ccr3
- salts
- Prior art date
Links
- 102100005861 CCR3 Human genes 0.000 title claims abstract 6
- 101700070842 CCR3 Proteins 0.000 title claims abstract 6
- 239000003112 inhibitor Substances 0.000 title claims abstract 5
- 230000002401 inhibitory effect Effects 0.000 title claims abstract 5
- 150000003839 salts Chemical class 0.000 title claims abstract 5
- 239000011780 sodium chloride Substances 0.000 title claims abstract 5
- 239000000126 substance Substances 0.000 claims abstract 12
- 201000010099 disease Diseases 0.000 claims abstract 4
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 4
- 230000002265 prevention Effects 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 102000004499 CCR3 Receptors Human genes 0.000 abstract 1
- 108010017316 CCR3 Receptors Proteins 0.000 abstract 1
Abstract
DC60 (05/04/56) การประดิษฐ์นี้เกี่ยวข้องกับผลึกร่วมเเละเกลือของสารยับยั้ง CCR3 ของสูตร 1 (สูตรเคมี) 1 องค์ประกอบทางเภสัชกรรมที่มีสารนี้ เเละวิธีการใช้สารนี้เป็นสารสำหรับรักษาเเละ/หรือป้องกันโรค ที่เกี่ยวข้องกับตัวรับ CCR3 การประดิษฐ์นี้เกี่ยวข้องกับผลึกร่วมเเละเกลือของสารยับยั้ง CCR3 ของสูตร 1 องค์ประกอบทางเภสัชกรรมที่มีสารนี้ เเละวิธีการใช้สารนี้สำหรับรักษาเเละ/หรือป้องกันโรค ที่เกี่ยวข้องกับตัวรับ CCR3 สิทธิบัตรยา DC60 (05/04/56) This invention involves co-crystalline and salt of the CCR3 inhibitor of Formula 1 (chemical formula) 1, a pharmaceutical component containing this substance. And how to use this substance as a substance for treatment and / or prevention of disease The invention involved the co-crystals and the CCR3 inhibitor salts of Formula 1, the pharmaceutical components containing this substance. And how to use this substance for treatment and / or prevention of disease Related to the drug patent CCR3 receptor
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH155318A true TH155318A (en) | 2016-08-11 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201300436A1 (en) | JOINT CRYSTALS AND SALTS OF CCR3 INHIBITORS | |
| TH155318A (en) | Co-crystals and salts of CCR3 inhibitors | |
| TH1501003494A (en) | PRMT5 inhibitors and their use | |
| TH145921A (en) | Heterocyclic Compound AS Histamine H3 Receptor Ligand | |
| TH129239A (en) | Triacene-Oxadiazole (Triazine-Oxadiazoles) | |
| TH157676A (en) | Pyrazole compounds as SGLT1 inhibitors | |
| TH167246A (en) | Biaryyl amide compounds As a kinase inhibitor | |
| TH147180A (en) | Notch trajectory signaling inhibitor compound | |
| TH146335A (en) | New derivatives of 1,2,3,4-tetrahydroquinoline useful for the treatment of diabetes. | |
| TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
| TH176363A (en) | Sulfonamides that are modified substances of sodium channel. | |
| TH158383A (en) | Heterocyclic compounds | |
| TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller | |
| TH169293A (en) | BACEI inhibitors | |
| TH156221A (en) | 4- (8-methoxy-1 - ((1-methoxipropane-2-il) -2- (tetrahydro-2H-pyran-4-il) - 1H-imidaiso [4.5-C] -quinolin-7-il) -3,5-dimethyl isosazole And their use as a bromodomain inhibitor. | |
| TH167426A (en) | Hetero-aeryl or bicyclic-bonded aryl compounds and their use That substance as an IRAK4 inhibitor | |
| TH134911A (en) | LXR modulater | |
| TH152477A (en) | New useful morpholinil derivative as a MOGAT-2 inhibitor | |
| TH168637A (en) | New heterocyclic compounds | |
| TH156862A (en) | Acrylamide compounds as histamine ligands H3 receptors | |
| TH182770A (en) | Aldosteron Synthes inhibitors | |
| TH151371A (en) | The 2-amino-4-aryl thiazole compound is an antagonist TRPA1. | |
| TH138979A (en) | New compound useful for the treatment of degenerative and inflammatory diseases | |
| TH156226A (en) | Compounds and compositions as c-kit kinase inhibitors | |
| TH1501005211A (en) | Elements for the treatment of sleep apnea |